Tapering Methotrexate with Biologics or JAK Inhibitors in RA Save
Dr Segan discusses Abstract 0916 at ACR22 Convergence. Abstract 0916: Should RA Patients with Controlled Disease Taper Methotrexate from Targeted Therapy or Continue It? Risk Differences in Sustaining Remission from a Systematic Review and Meta-analysis
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.